{"disease":{"id":"peripheral-lung-tumor","name":"peripheral lung tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02834013","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":818,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05918783","title":"Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Impact Biotech Ltd","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}